Recap: Cabaletta Bio Q4 Earnings
Portfolio Pulse from Benzinga Insights
Cabaletta Bio (NASDAQ:CABA) reported Q4 earnings with an EPS of $-0.46, missing estimates by -18.0%. Revenue remained unchanged from the previous year. In the last quarter, the company exceeded EPS estimates, leading to a 2.0% share price increase the following day.
March 21, 2024 | 1:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cabaletta Bio reported a Q4 EPS of $-0.46, missing estimates by -18.0%, with unchanged revenue from last year.
Missing earnings estimates typically leads to negative investor sentiment in the short term, potentially causing a decrease in stock price. The previous quarter's performance, where a beat in EPS estimates led to a stock price increase, further emphasizes the impact of earnings reports on CABA's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100